Humanigen, Inc. reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported net loss was USD 33.54 million compared to USD 32.3 million a year ago. Basic loss per share from continuing operations was USD 0.53 compared to USD 0.63 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | +100.00% | -.--% | -83.33% |
05-01 | Combined Hearing for Disclosure Statement and Plan Approved for Humanigen, Inc. | CI |
04-12 | Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-83.33% | 11.91K | |
-2.29% | 89.38B | |
-3.95% | 37.92B | |
-13.07% | 32.04B | |
+63.05% | 26.03B | |
-22.14% | 14.14B | |
-7.96% | 12.88B | |
-9.33% | 11.77B | |
-46.33% | 10.85B | |
+5.77% | 8.92B |
- Stock Market
- Equities
- HGENQ Stock
- News Humanigen, Inc.
- Humanigen, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021